NEWS
- HER2 Targeted Therapies In Breast Cancer
- Basic Information About Sacituzumab Govitecan
- Patterns of Antibody Therapy For Breast Cancer
- First Immunotherapy For Early-stage Triple-negative Breast Cancer
- ADC Drug Trodelvy Shows Positive Efficacy In three Types of Cancers
- PEG Linkers for Antibody Drug Conjugates - Biochempeg
- Novel Drugs Approved By FDA in 2021
- FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) - First CD19-targeted ADC
- FDA Approved Antibody-Drug Conjugates (ADCs) Up To 2022
- FDA Approved PEGylated Drugs Up To 2022